Hochschulschrift
The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Göttingen, Georg-August Universität, Diss., 2014
- Keyword
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Event
-
Veröffentlichung
- (where)
-
Göttingen
- (who)
-
Niedersächsische Staats- und Universitätsbibliothek Göttingen
- (when)
-
2015
- Creator
-
Bouter, Yvonne
- Contributor
-
Bayer, Thomas A.
Hanisch, Uwe-Karsten
Ehrenreich, Hannelore
- Handle
-
11858/00-1735-0000-0023-9978-E
- URN
-
urn:nbn:de:gbv:7-11858/00-1735-0000-0023-9978-E-9
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Bouter, Yvonne
- Bayer, Thomas A.
- Hanisch, Uwe-Karsten
- Ehrenreich, Hannelore
- Niedersächsische Staats- und Universitätsbibliothek Göttingen
Time of origin
- 2015
Other Objects (12)
The contribution of N-terminally modified amyloid beta to the etiology of Alzheimer's disease
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Copper binding to the Alzheimer’s disease amyloid precursor protein
The role of ATP-binding cassette subfamily A in the etiology of Alzheimer’s disease
Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques
The amyloid hypothesis of Alzheimer's disease at 25 years
The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Degree of amyloid-β burden could be indicative of the primary etiology underlying dementia
Amyloid PET imaging: applications beyond Alzheimer’s disease
The contribution of N-terminally modified amyloid beta to the etiology of Alzheimer's disease
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Copper binding to the Alzheimer’s disease amyloid precursor protein
The role of ATP-binding cassette subfamily A in the etiology of Alzheimer’s disease
Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques
The amyloid hypothesis of Alzheimer's disease at 25 years
The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Degree of amyloid-β burden could be indicative of the primary etiology underlying dementia
Amyloid PET imaging: applications beyond Alzheimer’s disease
The contribution of N-terminally modified amyloid beta to the etiology of Alzheimer's disease
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Copper binding to the Alzheimer’s disease amyloid precursor protein
The role of ATP-binding cassette subfamily A in the etiology of Alzheimer’s disease
Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques
The amyloid hypothesis of Alzheimer's disease at 25 years
The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Degree of amyloid-β burden could be indicative of the primary etiology underlying dementia